NASDAQ: CTKB
Cytek Biosciences Inc Stock Ownership - Who owns Cytek Biosciences?

Insider buying vs selling

Have Cytek Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Wenbin JiangCEO;Pres2026-08-182,869$4.67
$13.40kSell
Wenbin JiangCEO;Pres2026-08-185,382$4.67
$25.13kSell
Wenbin JiangCEO;Pres2026-08-187,062$4.67
$32.98kSell
Ming YanCTO2026-08-181,778$4.67
$8.30kSell
William D. McCombeCFO2026-08-185,401$4.67
$25.22kSell
William D. McCombeCFO2026-08-184,392$4.67
$20.51kSell
William D. McCombeCFO2026-08-182,111$4.67
$9.86kSell
Ming YanCTO2026-08-183,463$4.67
$16.17kSell
Ming YanCTO2026-08-181,346$4.67
$6.29kSell
Ming YanCTO2026-08-181,501$4.67
$7.01kSell

1 of 7

CTKB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CTKB insiders and whales buy or sell their stock.

CTKB Shareholders

What type of owners hold Cytek Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP10.29%13,381,054$80.02MInsider
Wenbin Jiang6.33%8,227,629$49.20MInsider
Ming Yan3.71%4,821,870$28.83MInsider
Feng Deng0.34%443,800$2.65MInsider
Valerie Barnett0.12%150,012$897.07kInsider
William D. McCombe0.10%134,693$805.46kInsider
Patrik Jeanmonod0.07%97,465$582.84kInsider
Patrick Jeanmonod0.07%95,997$574.06kInsider
Jack Ball0.07%86,678$518.33kInsider
Michael Holder0.05%62,875$375.99kInsider

1 of 3

CTKB vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CTKB0.06%21.39%Net SellingNet Selling
KIDS0.06%99.94%Net SellingNet Selling
INMD0.05%12.97%
VREX0.10%2.08%Net SellingNet Buying
AHCO0.08%99.92%Net BuyingNet Buying

Cytek Biosciences Stock Ownership FAQ

Who owns Cytek Biosciences?

Cytek Biosciences (NASDAQ: CTKB) is owned by 0.06% institutional shareholders, 21.39% Cytek Biosciences insiders, and 78.55% retail investors. Ra Capital Management LP is the largest individual Cytek Biosciences shareholder, owning 13.38M shares representing 10.29% of the company. Ra Capital Management LP's Cytek Biosciences shares are currently valued at $82.16M.

If you're new to stock investing, here's how to buy Cytek Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.